Harland & Wolff Group Gets GBP61 Million Contract for Vessel Refurbishment
By Elena Vardon
Harland & Wolff Group Holdings said it was awarded 61 million-pound ($74.1 million) contract for a major vessel refurbishment by Canadian oil and natural-gas company Cenovus Energy.
The U.K. strategic-infrastructure-projects company said Friday that revenue from the contract are included within management's revenue expectations of GBP100 million for 2023 and GBP200 million for 2024. Around GBP10 million is expected to be received in 2023, with the rest the following year.
The contract award follows a letter of intent issued in late July
The vessel, which is should arrive in the first quarter of 2024, will be in its building dock for more than three months. Pre-arrival works have kicked off and some fabrication works will start before the end of the year, Harland & Wolff said. Up to 1,000 people will be working on the vessel at its peak, including staff and subcontractors, it said.
Write to Elena Vardon at elena.vardon@wsj.com
(END) Dow Jones Newswires
October 20, 2023 02:51 ET (06:51 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks